Xiaoqin Su

1.3k citations
32 papers · 1.1k indexed · h-index 15
Topics
Cerebrovascular and Carotid Artery Diseases (7 papers)Acute Ischemic Stroke Management (7 papers)Natural product bioactivities and synthesis (4 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xiaoqin Su

31 papers receiving 1.1k citations

Peers

Xiaoqin Su
Comparison fields: 5 of 103
  • Immunology 586
  • Molecular Biology 298
  • Epidemiology 131
  • Cancer Research 96
  • Pulmonary and Respiratory Medicine 89
Replace Petya Dimitrova with:
Petya Dimitrova Bulgaria
Stephan Dreschers Germany
Wing Keung Chan United States
Hang Zhang China
Yanhua Kang China
Xiaodan Qu China
Chen‐Hao Yeh United States
Yujie Ren China
Seyedeh Hoda Alavizadeh Iran
Hua Tang China
Xiaoqin Su relative to Petya Dimitrova Bulgaria Petya Dimitrova's profile →
Citations per field
00.5×2.9×
Petya Dimitrova · 1×
Citations per year

Countries citing papers authored by Xiaoqin Su

Since Specialization
Citations

This map shows the geographic impact of Xiaoqin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqin Su more than expected).

Fields of papers citing papers by Xiaoqin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoqin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqin Su. The network helps show where Xiaoqin Su may publish in the future.

Co-authorship network of co-authors of Xiaoqin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqin Su. A scholar is included among the top collaborators of Xiaoqin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqin Su. Xiaoqin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 5
4 17
5 19
6 14
7 3
8 3
9 17
10 4
11 14
12 20
13 30
14 37
15 52
16 63
17 32
18 382
19 50
20
Abnormal expression of hepatomas and circulating telomerase and its clinical values.
11

About Xiaoqin Su

Xiaoqin Su is a scholar working on Internal Medicine, Behavioral Neuroscience and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (7 papers), Acute Ischemic Stroke Management (7 papers) and Natural product bioactivities and synthesis (4 papers). The work is most often cited by research in Immunology (586 citations), Cancer Research (96 citations) and Complementary and alternative medicine (43 citations). Xiaoqin Su has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hong‐Bing Shu, Liang‐Guo Xu, Lianghua Bin, Jun Zhang, Ke-Jun Han, Sawsan Youssef, Lawrence Steinman, Nicole Baumgarth, Yueh-hsiu Chien and Luke Li. Their work appears in journals such as Journal of Biological Chemistry, Immunity and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026